TY  - CHAP
AU  - Xavier Lévêque
AU  - Kyle Fink
AU  - Julien Rossignol
AU  - Gary L Dunbar
AU  - Laurent Lescaudron
ED  - Shuji Miyagawa
Y1  - 2012-02-03
PY  - 2012
T1  - The Use of Xenotransplantation in Neurodegenerative Diseases: A Way to Go?
N2  - Accompanied by the advent of animal cloning, the technique of nuclear transfer produced alpha1,3-galactosyltransferase-knockout (Gal-KO) pigs in many institutes, including the ones in Japan, at the beginning of 21st Century. In addition, the controversy of the risks of PERV has gradually minimized, because of the fact that there are no cases of PERV infections reported in humans. Furthermore, a large clinical wave for islet allotransplantation resumed the interest of xenotransplantation, especially porcine islet transplantation and some exceptions. Clinical trials were done in many countries so far, such as Sweden, China, Mexico, USA  (Inventory of Human Xenotransplantation Practices - IXA and HUG in collaboration with WHO). In addition, a new clinical trial was approved by the government, and resumed the porcine islet transplantation research in New Zealand two years ago.
BT  - Xenotransplantation
SP  - Ch. 7
UR  - https://doi.org/10.5772/29805
DO  - 10.5772/29805
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -